Health
Regeneron suspends Covid-19 antibody trial among sickest patients – Macau Business
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients…
-
General21 hours agoHeroic surfing priest rescues father and son from rip at Cable Beach
-
Noosa News22 hours agoBike riders to cycle across the traffic lanes of the Story Bridge
-
Noosa News24 hours agoQueensland braces for cold snap with below-average temperatures and frost
-
General22 hours agoGiant dinosaur impulse buy becomes Milang town mascot